These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15065567)

  • 1. Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease.
    Embers ME; Ramamoorthy R; Philipp MT
    Microbes Infect; 2004 Mar; 6(3):312-8. PubMed ID: 15065567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune escape strategies of Borrelia burgdorferi.
    Aslam B; Nisar MA; Khurshid M; Farooq Salamat MK
    Future Microbiol; 2017 Oct; 12():1219-1237. PubMed ID: 28972415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular survival strategies of the Lyme disease spirochete Borrelia burgdorferi.
    Singh SK; Girschick HJ
    Lancet Infect Dis; 2004 Sep; 4(9):575-83. PubMed ID: 15336225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of moderately infectious Borrelia burgdorferi sensu stricto from attenuated cultures by using complement-mediated, antibody-dependent lysis selection technique in a mammalian tissue co-culture system.
    Sen E; Schell RF
    Microbes Infect; 2003 Aug; 5(10):869-78. PubMed ID: 12919855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement evasion by the Lyme disease spirochete Borrelia burgdorferi grown in host-derived tissue co-cultures: role of fibronectin in complement-resistance.
    Güner ES
    Experientia; 1996 Apr; 52(4):364-72. PubMed ID: 8620942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity in borreliosis with special emphasis on the role of complement.
    Ekdahl KN; Henningsson AJ; Sandholm K; Forsberg P; Ernerudh J; Ekerfelt C
    Adv Exp Med Biol; 2007; 598():198-213. PubMed ID: 17892213
    [No Abstract]   [Full Text] [Related]  

  • 7. Borrelia burgdorferi--traveling incognito?
    Fikrig E; Narasimhan S
    Microbes Infect; 2006 Apr; 8(5):1390-9. PubMed ID: 16698304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasticity in early immune evasion strategies of a bacterial pathogen.
    Bernard Q; Smith AA; Yang X; Koci J; Foor SD; Cramer SD; Zhuang X; Dwyer JE; Lin YP; Mongodin EF; Marques A; Leong JM; Anguita J; Pal U
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3788-E3797. PubMed ID: 29610317
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement evasion by Borrelia burgdorferi: it takes three to tango.
    de Taeye SW; Kreuk L; van Dam AP; Hovius JW; Schuijt TJ
    Trends Parasitol; 2013 Mar; 29(3):119-28. PubMed ID: 23298533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Evasion by Lyme Disease Spirochetes.
    Skare JT; Garcia BL
    Trends Microbiol; 2020 Nov; 28(11):889-899. PubMed ID: 32482556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.
    Rogovskyy AS; Gillis DC; Ionov Y; Gerasimov E; Zelikovsky A
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27799330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of host immune cells and Borrelia burgdorferi antigens in the etiology of Lyme disease.
    Verhaegh D; Joosten LAB; Oosting M
    Eur Cytokine Netw; 2017 Jun; 28(2):70-84. PubMed ID: 28840838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent Infection of the Human Brain with Multiple
    Golovchenko M; Opelka J; Vancova M; Sehadova H; Kralikova V; Dobias M; Raska M; Krupka M; Sloupenska K; Rudenko N
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. vls Antigenic Variation Systems of Lyme Disease Borrelia: Eluding Host Immunity through both Random, Segmental Gene Conversion and Framework Heterogeneity.
    Norris SJ
    Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens.
    Bankhead T; Chaconas G
    Mol Microbiol; 2007 Sep; 65(6):1547-58. PubMed ID: 17714442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between host immune response and antigenic variation that control Borrelia burgdorferi population dynamics.
    Zhou W; Brisson D
    Microbiology (Reading); 2017 Aug; 163(8):1179-1188. PubMed ID: 28771127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rhesus model of Lyme neuroborreliosis.
    Pachner AR; Gelderblom H; Cadavid D
    Immunol Rev; 2001 Oct; 183():186-204. PubMed ID: 11782257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immunity networks during infection with Borrelia burgdorferi.
    Oosting M; Buffen K; van der Meer JW; Netea MG; Joosten LA
    Crit Rev Microbiol; 2016; 42(2):233-44. PubMed ID: 24963691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-pathogen interactions and the pathogenesis of murine Lyme disease.
    Weis JJ
    Curr Opin Rheumatol; 2002 Jul; 14(4):399-403. PubMed ID: 12118174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New aspects of pathogenesis of Lyme borreliosis].
    Zajkowska J; Grygorczuk S; Kondrusik M; Pancewicz S; Hermanowska-Szpakowicz T
    Przegl Epidemiol; 2006; 60 Suppl 1():167-70. PubMed ID: 16909797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.